Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 144 publications
A High-Value, Cross-Continuum Approach to Heart Failure: A Narrative Review.
Journal: The American journal of medicine
Published: July 01, 2026
Low-Dose Rivaroxaban Plus Aspirin in Patients With PAD Undergoing Lower Extremity Revascularization With and Without History of Prior Limb Revascularization: Insight From the VOYAGER-PAD Trial.
Journal: Circulation. Cardiovascular interventions
Published: February 27, 2026
Low-Dose Rivaroxaban Plus Aspirin in Patients With PAD Undergoing Lower Extremity Revascularization With and Without History of Prior Limb Revascularization: Insight From the VOYAGER-PAD Trial.
Journal: Circulation. Cardiovascular interventions
Published: February 27, 2026
Development of new antithrombotic drugs for children (part 1): guidance from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis and the Pedi-ATLAS Group.
Journal: Journal of thrombosis and haemostasis : JTH
Published: January 01, 2026
Prescription of aspirin plus low-dose rivaroxaban in patients with peripheral artery disease after lower-extremity revascularization.
Journal: Vascular medicine (London, England)
Published: April 30, 2025
Early Risk of Major Adverse Limb Events Following Lower Extremity Revascularization in the VOYAGER-PAD Trial.
Journal: JACC. Cardiovascular interventions
Published: December 18, 2024
Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis.
Journal: Journal of the American Heart Association
Published: May 23, 2024
Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial.
Journal: Journal of the American Heart Association
Published: April 02, 2024
Methods, design, and initial results of an angiographic core lab from VOYAGER-PAD.
Journal: Vascular medicine (London, England)
Published: March 17, 2024
Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD.
Journal: Circulation
Published: February 20, 2024
Long-term Antithrombotic Therapy in Patients With Chronic Coronary Syndrome: An Updated Review of Current Evidence.
Journal: Clinical therapeutics
Published: February 19, 2024
Last Updated: 09/26/2026